The Center for Prostate Disease Research (CPDR) at Walter Reed Army Medical Center (WRAMC) has a special clinic for men diagnosed with prostate cancer called the “Multi-Disciplinary Prostate Cancer Clinic”.

This a FREE new handbook developed specifically for men with advanced prostate cancer. The outline of the handbook was based on extensive research with advanced prostate cancer survivors to determine what they needed and wanted to know.

Vietnam veterans diagnosed with prostate cancer may qualify for service-connected disability compensation. Veterans who served in Korea in 1968 or 1969 may also qualify.

This is where CPDR lists reciprocal links with other prostate cancer related sites and collaborations with other research institutes.

An interactive presentation of the anatomy of the prostate, research methods and clinical stages related to prostate cancer.
Macromedia Flash Player is required to view this presentation.
Download Flash Player Launch Presentation

A partnership project of the American Cancer Society and the Cancer Research Institute, this website provide basic information on both the prostate and prostate cancer. It instructs readers on the significance of PSA blood tests and what happens when cancer id found. It also guides patients through choosing a therapy, as well as where to look for information on new investigational treatments. A "learn more" section lists books, support groups, and websites that all deal with prostate cancer.

Are you thinking about getting screened for prostate cancer or do you know someone who is? "Prostate Cancer Screening: A Decision Guide" is designed to help a man decide whether screening is right for him. The 17-page guide discusses the prostate, prostate cancer, and the screening tests in an easy-to-read question and answer format.

Once the diagnosis of adenocarcinoma (cancer) is made, it is important to determine the histologic grade of the tumor – i.e. the degree of aggressiveness of the tumor. Low-grade tumors progress slowly whereas high-grade tumors grow rapidly and may have adverse outcome . . .

"Our data shows that the PSA test, which helps to detect prostate cancer at an early stage, saves lives, and should be offered to all men over a certain age." says Dr, Judd W. Moul, Director of the Center for Prostate Disease Research (CPDR) for two new studies based on data from the military underscore...

Patients whose only sign of recurrence after local therapy for prostate cancer is a rising prostate-specific antigen level (PSA-only recurrence) have become more common. We have developed two models to predict PSA-only recurrence after radical prostatectomy.

Interactive Equations designed by CPDR to help in the calculation of Pre- and Post-Operative Risk Recurrence.

These biostatistical models predicting the risk of recurrence after radical prostatectomy for clinically localized prostate cancer are necessary.